瑞典人群队列研究:结节病心力衰竭风险及预测因素
OBJECTIVES: Previous studies showed a strong association between sarcoidosis and heart failure (HF) but did not consider risk stratification or risk factors to identify useful aetiological insights.…
要点
- 结节病患者心衰率显著升高(HR 2.43),诊断后2年内风险最高(HR 3.7)。
- 无缺血性心脏病史者风险仍增高(HR 2.7),提示非缺血机制。
- 糖尿病、房颤和其他心律失常为最强独立预测因素(HR各2.5)。
核心结论
- 结节病患者心衰发生率是普通人群2倍以上,诊断后初期风险最高。
- 缺血性心脏病史不能完全解释风险,室性心律失常提示心脏结节病并预测心衰。
研究设计与样本
- Cox模型校正人口学和合并症,评估心衰风险比及独立预测因素与归因分数。
主要发现
- 随访期间结节病组204例、对照组721例诊断心衰,发生率2.2 vs 0.7/1000人年。
- 结节病心衰校正HR 2.43(95%CI 2.06-2.86),年龄、性别或治疗状态无差异。
- 诊断后2年内HR 3.7,无缺血性心脏病史者HR 2.7。
- 糖尿病、房颤、其他心律失常HR均为2.5,2年归因分数20%、16%、12%。
临床怎么用
- 对结节病患者,尤其诊断初期,应关注心衰症状并筛查心律失常。
- 合并糖尿病或房颤/心律失常的结节病患者需更积极评估心功能。
- 无缺血性心脏病史不能排除心衰风险,心律失常提示心脏结节病可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Previous studies showed a strong association between sarcoidosis and heart failure (HF) but did not consider risk stratification or risk factors to identify useful aetiological insights. We estimated overall and stratified HRs and identified risk factors for HF in sarcoidosis. METHODS: Sarcoidosis cases were identified from the Swedish National Patient Register (NPR; ≥2 International Classification of Diseases-coded visits, 2003-2013) and matched to general population comparators. They were followed for HF in the NPR. Treated were cases who were dispensed ≥1 immunosuppressant ±3 months from the first sarcoidosis visit (2006-2013). Using Cox models, we estimated HRs adjusted for demographics and comorbidity and identified independent risk factors of HF together with their attributable fractions (AFs). RESULTS: During follow-up, 204 of 8574 sarcoidosis cases and 721 of 84 192 comparators were diagnosed with HF (rate 2.2 vs 0.7/1000 person-years, respectively). The HR associated with sarcoidosis was 2.43 (95% CI 2.06 to 2.86) and did not vary by age, sex or treatment status. It was higher during the first 2 years after diagnosis (HR 3.7 vs 1.9) and in individuals without a history of ischaemic heart disease (IHD; HR 2.7 vs 1.7). Diabetes, atrial fibrillation and other arrhythmias were the strongest independent clinical predictors of HF (HR 2.5 each, 2-year AF 20%, 16% and 12%, respectively). CONCLUSIONS: Although low, the HF rate was more than twofold increased in sarcoidosis compared with the general population, particularly right after diagnosis. IHD history cannot solely explain these risks, whereas ventricular arrhythmias indicating cardiac sarcoidosis appear to be a strong predictor of HF in sarcoidosis.
引用
- Rossides M, Kullberg S, Grunewald J, et al. Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden. Heart. 2021. PMID: 34021039. doi:10.1136/heartjnl-2021-319129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。